Latest Options News

Titan Minerals Limited has entered an underwriting agreement with CPS Capital Group to cover a $2.8 million options shortfall, ensuring funding for its Dynasty Gold Project and working capital needs.

Hawthorn Resources has completed a pivotal Pre-Feasibility Study for its Mt Bevan Magnetite project and strategically converted its equity stake into a royalty, positioning the company for future value capture amid evolving market dynamics.

Inca Minerals Limited reported steady progress in its December 2024 quarterly activities, focusing on refining exploration targets and securing funding while navigating regulatory and operational challenges.

Betashares Capital Ltd has announced an estimated distribution of 8.02 cents per unit for its Western Asset Australian Bond Active ETF for January 2025, with key dates set for early February.

Jameson Resources Limited has made significant progress in environmental approvals for its Crown Mountain Hard Coking Coal Project, while community and political backing for the coal sector in Canada strengthens. The company plans to resubmit its Environmental Impact Statement by mid-2025.

Mako Gold Limited has agreed to a takeover by Aurum Resources, creating a stronger gold exploration entity in West Africa with over A$20 million in cash to accelerate development at key projects.

West Cobar Metals reports significant resource expansions at its Salazar project alongside promising copper-antimony test results at Bulla Park, while aggressively trimming costs to extend its runway.

Magnum Mining and Exploration Limited moves forward with acquiring two promising rare earth element projects in Brazil while progressing negotiations on a green pig iron venture in Saudi Arabia.

Zenith Minerals reported a 40% increase in its Dulcie Far North gold resource and secured A$2.48 million in new funding, positioning the company for aggressive exploration across its Australian gold and lithium projects.

A1 Investments & Resources Ltd reports a modest cash outflow for the June 2024 quarter while actively pursuing acquisitions and planning convertible note funding to support growth.

Clara Resources outlines key progress on its Ashford Coking Coal Project drilling preparations and details ongoing capital management initiatives, including rights issues and entitlement offers, while navigating boardroom challenges.

Paradigm Biopharmaceuticals has secured FDA clearance for its phase 3 knee osteoarthritis trial and raised $16 million to fund its next clinical steps, positioning the company for a pivotal year ahead.